Mark Bushfield - Abcam Plc Scientific Director
| ABCZF Stock | USD 22.25 0.00 0.00% |
Director
Dr. Mark Bushfield Ph.D. is Scientific Director of Abcam Plc. Mark joined Abcam in 2008 and is responsible for global innovation and manufacturing. Mark is a biologist with over 20 years research and management experience in academia pharma and biotechnology. Prior to joining Abcam Mark trained in cellular signalling and then worked for Pfizer before cofounding Cambridge Drug Discovery Ltd . After successfully integrating CDD into BioFocus Mark joined Celltech as research director then VP research at UCBCelltech. Mark has coauthored over 30 peer reviewed scientific papers and given over 40 presentations to scientific meetings and societies.
| Professional Marks | Ph.D |
| Phone | 44 12 2369 6000 |
| Web | https://www.abcam.com |
Abcam Plc Management Efficiency
The company has return on total asset (ROA) of 0.0326 % which means that it generated a profit of $0.0326 on every $100 spent on assets. This is way below average. Abcam Plc's management efficiency ratios could be used to measure how well Abcam Plc manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 12 records | DIRECTOR Age | ||
| Anne Kverneland | Novo Nordisk AS | 64 | |
| Mette Jensen | Novo Nordisk AS | 45 | |
| Stig Stroebaek | Novo Nordisk AS | 55 | |
| Mark Dehring | CSL Limited | N/A | |
| Andreas Fibig | Novo Nordisk AS | 59 | |
| Thomas Rantzau | Novo Nordisk AS | 46 | |
| Kasim Kutay | Novo Nordisk AS | 55 | |
| Liz Hewitt | Novo Nordisk AS | 64 | |
| Sylvie Gregoire | Novo Nordisk AS | 59 | |
| Martin Mackay | Novo Nordisk AS | 64 | |
| Laurence Debroux | Novo Nordisk AS | 51 | |
| Brian Daniels | Novo Nordisk AS | 61 | |
Management Performance
| Return On Equity | 0.0069 | |||
| Return On Asset | 0.0326 |
Abcam plc Leadership Team
Elected by the shareholders, the Abcam Plc's board of directors comprises two types of representatives: Abcam Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Abcam. The board's role is to monitor Abcam Plc's management team and ensure that shareholders' interests are well served. Abcam Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Abcam Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark Dermody, Interim CIO | ||
| Kirstie BBusSc, Head Insights | ||
| Mark Bushfield, Scientific Director | ||
| Michael BA, CFO Director | ||
| Emma Sceats, Service Sales | ||
| James Staveley, Vice President - Investor Relations | ||
| Marc Perkins, Interim Company Secretary | ||
| Nick Skinner, VP HR | ||
| BS MBA, CEO Director | ||
| Yvonne Chien, Chief Digital Officer |
Abcam Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Abcam Plc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0069 | |||
| Return On Asset | 0.0326 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 3.69 B | |||
| Shares Outstanding | 229.27 M | |||
| Shares Owned By Insiders | 16.20 % | |||
| Shares Owned By Institutions | 66.10 % | |||
| Price To Earning | 199.38 X | |||
| Price To Book | 3.96 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abcam plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Abcam plc information on this page should be used as a complementary analysis to other Abcam Plc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Abcam Pink Sheet analysis
When running Abcam Plc's price analysis, check to measure Abcam Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abcam Plc is operating at the current time. Most of Abcam Plc's value examination focuses on studying past and present price action to predict the probability of Abcam Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abcam Plc's price. Additionally, you may evaluate how the addition of Abcam Plc to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |